caa a22 4500 606158375 CHVBK 20210128100619.0 cr unu---uuuuu 210128e20151201xx s 000 0 eng 10.1007/s10557-015-6622-5 doi (NATIONALLICENCE)springer-10.1007/s10557-015-6622-5 Exogenous SDF - 1α Protects Human Myocardium from Hypoxia - Reoxygenation Injury via CXCR4 [Elektronische Daten] [A. Malik, D. Bromage, Z. He, L. Candilio, A. Hamarneh, S. Taferner, S. Davidson, D. Yellon] The Author(s), 2015 SDF-1α nationallicence Stromal derived factor nationallicence CXCR4 nationallicence Ischaemia-reperfusion injury nationallicence Cardioprotection nationallicence Malik A. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Bromage D. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut He Z. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Candilio L. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Hamarneh A. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Taferner S. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Davidson S. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Yellon D. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut Cardiovascular Drugs and Therapy Springer US; http://www.springer-ny.com 29/6(2015-12-01), 589-592 0920-3206 29:6<589 2015 29 10557 https://doi.org/10.1007/s10557-015-6622-5 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 brief-communication jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10557-015-6622-5 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Malik A. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- Bromage D. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- He Z. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- Candilio L. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- Hamarneh A. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- Taferner S. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- Davidson S. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 700 1- Yellon D. The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, WC1E 6HX, London, UK aut NATIONALLICENCE 773 0- Cardiovascular Drugs and Therapy Springer US; http://www.springer-ny.com 29/6(2015-12-01), 589-592 0920-3206 29:6<589 2015 29 10557